01 8Bydureon
02 2Bydureon
03 6Byetta
04 2Byetta
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 68
2019 Revenue in Millions : 110
Growth (%) : -38
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 448
2019 Revenue in Millions : 549
Growth (%) : -18
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 385
2020 Revenue in Millions : 448
Growth (%) : -14
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 55
2020 Revenue in Millions : 68
Growth (%) : -19
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 280
2021 Revenue in Millions : 385
Growth (%) : -27
Main Therapeutic Indication : Diabetes
Currency : USD
2023 Revenue in Millions : 163
2022 Revenue in Millions : 280
Growth (%) : -42
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 440
2014 Revenue in Millions : 580
Growth (%) : 32%
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 327
2014 Revenue in Millions : 316
Growth (%) : -3%
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 176
2016 Revenue in Millions : 254
Growth (%) : -31
Main Therapeutic Indication : Diabetes
Currency : USD
2017 Revenue in Millions : 574
2016 Revenue in Millions : 578
Growth (%) : -1
LOOKING FOR A SUPPLIER?
